Clinical trial
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
NCT00413504 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00413504 |
|---|---|
| Title | Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism |
| Official title | Fondaparinux as Monotherapy for Deep Vein Thrombosis and/or Pulmonary Embolism (Pilot Study) |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Fondaparinux |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Dec 19, 2006 |
| Last update posted | Feb 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: